← Leaderboards
Georges Michel Verjans
University Of Pittsburgh At Pittsburgh
$1,634,847
Attributed
$3,491,905
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $728.9K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,491,905 · 1
By mechanism
R01$3,491,905 · 1
Top collaborators
- Paul R. Kinchington5 shared
- Randall J. Cohrs1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Paul R. Kinchington$19,833,198
- Jami Lynn Saloman$3,719,308
- Neal A. Deluca$20,635,232
- James F. Conway$10,576,068
- Joseph C. Glorioso$19,383,290
Others in their field
Other Emerging Leaders on “Genetic Transcription”
- Evan Z Macosko · Broad Institute, Inc.$30,129,032
- Sonia Minikel Vallabh · Broad Institute, Inc.$14,507,691
- Tomasz Nowakowski · University Of California, San Francisco$12,105,692
- Chun Jimmie Ye · Feinstein Institute For Medical Research$11,595,683
- Yin Shen · University Of California, San Francisco$10,418,368
- Chongyuan Luo · University Of California Los Angeles$9,805,856
Research focus
Genetic TranscriptionHerpesvirus Type 3Gene FunctionGenetic Regulatory ProteinGenomicsHerpesviridaeElementsGene ExpressionElderlyGenesGangliaChickenpoxFda ApprovedChromatinChromatin ImmunoprecipitationBindingChronicAnimal ModelCodeBlindnessCadaverDesignAfferent NeuronsHerpes Zoster Disease
Grant awards (5)
Role of VZV Latency Transcript (VLT) and ORF63 in latency and reactivation$673,220
R01 · FY2025 · AI
Role of VZV Latency Transcript (VLT) and ORF63 in latency and reactivation$709,789
R01 · FY2024 · AI
Role of VZV Latency Transcript (VLT) and ORF63 in latency and reactivation$713,338
R01 · FY2023 · AI
Role of VZV Latency Transcript (VLT) and ORF63 in latency and reactivation$728,923
R01 · FY2022 · AI
Role of VZV latency transcript (VLT) and ORF63 in latency and reactivation$666,635
R01 · FY2021 · AI